Sep 06, 2023 / 07:45PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good afternoon. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with DexCom. With us, we have Jereme Sylvain, the CFO. In terms of format, it's going to be a fireside chat. If anybody has a question, please raise your hand. We'll come around with the mic.
Jereme, thanks so much for being here.
Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO
Thanks for having us, Larry. Appreciate it. Yes.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystSo obviously, with GLP -- GLP-1 continue to be top of mind for a lot of investors. You guys put out some interesting data yesterday. I'd love to -- for people who haven't seen it, and even people who have -- I'd love to hear from you, kind of what the highlights are from that data and what
Trustpilot
